TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Archer Materials ( (AU:AXE) ) is now available.
Archer Materials has announced successful initial results from its collaboration with IMEC on the development of a silicon-based Biochip for blood potassium sensing. The silicon devices achieved a potassium sensing accuracy of ±0.3 mM, matching clinical standards and offering faster readout times compared to current technologies. This advancement de-risks the Biochip supply chain, reduces costs, and accelerates commercialization. Archer plans to further refine the technology and pursue regulatory approvals, aiming for clinical trials and productization focused on chronic kidney disease diagnostics.
The most recent analyst rating on (AU:AXE) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Archer Materials stock, see the AU:AXE Stock Forecast page.
More about Archer Materials
Archer Materials Limited is a quantum technology company focused on developing advanced semiconductor chips for quantum technology and medical diagnostics.
Average Trading Volume: 493,461
Technical Sentiment Signal: Buy
Current Market Cap: A$104.5M
See more data about AXE stock on TipRanks’ Stock Analysis page.